NTRA: Natera, Inc. Stock

SIC 8071 – Medical Laboratories

Valuation
Market Cap ($M) 10,991.38
Enterprise Value ($M) 10,712.63
Book Value ($M) 765.33
Book Value / Share 6.34
Price / Book 14.36
NCAV ($M) 582.18
NCAV / Share 4.82
Price / NCAV 18.88

Profitability (mra)
Return on Invested Capital (ROIC) -0.36
Return on Assets (ROA) -0.33
Return on Equity (ROE) -0.67

Liquidity (mrq)
Quick Ratio 3.96
Current Ratio 4.10

Balance Sheet (mrq) ($M)
Current Assets 1,258.55
Assets 1,441.70
Liabilities 676.37
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,082.57
Operating Income -446.25
Net Income -434.80
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -246.96
Cash from Investing 168.50
Cash from Financing 254.46

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Alger Associates Inc 5.90 -21.14
02-13 13G/A Vanguard Group Inc 9.13 10.32
01-31 13G BlackRock Inc. 5.20 14.46
01-23 13G/A Jpmorgan Chase & Co 6.60 28.22

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-23 127,748 420,326 30.39
2024-04-22 201,675 426,567 47.28
2024-04-19 239,797 910,858 26.33
2024-04-18 202,657 392,648 51.61

(click for more detail)

Similar Companies
FTRE – Fortrea Holdings Inc. GH – Guardant Health, Inc.


Financial data and stock pages provided by
Fintel.io